Skip to main content
. 2018 Nov 27;7:289–296. doi: 10.1007/s40204-018-0103-4

Fig. 9.

Fig. 9

Antimicrobial activity of the nanocomposite against (1) B. subtilis (2) K. pneumonia. a 50 µg, b 100 µg, c 200 µg and d 500 µg